ã¼ãã®ããããããããããã®ã¦ã¤ã«ã¹ã§äººãç æ°ã«ãã¦ã¿ããã²ã¼ã
ï¼Disclaimer: ããã§ç´¹ä»ããã²ã¼ã ã¯ã¦ã¤ã«ã¹ç®ç·ã§èãããã¨ã§ãã©ãããã°ã¦ã¤ã«ã¹ææã«å¯¾æã§ããããèãã¦ãããæè²ç®çã®ãã®ã§ããã¦ã¤ã«ã¹ææçã«ãã£ã¦äº¡ããªã£ãæ¹ãå¾éºçã«è¦ãã¾ãã¦ããæ¹ãé¡æã¨ãã¦éã¶æå³ã¯ä¸åããã¾ãããï¼
ã¢ã¦ããªã¼ãæ´»åãªããã®ãããæ©ä¼ãã¡ãã»ãåºã¦ãã¦ãé«æ ¡çã¨ã大人ãªæ¹ã ãç¸æã«ãããã¹ããããããã¯ã©ãã¨ãããã¨ã¯ãªãããã§ãããå°å¦çã¨ãªãã¨ã¡ãã£ã¨èããå¿ è¦ãåºã¦ããããã§ãããã¨è¨ã£ã¦ãèªåãå°å¦çã ã£ãããã«ãææ´ãããããã¾ããããã¼ããªãã¦ãã¤ã¬ã¯ã®ã»ã³ã»ã¤ã«è¨ãããæ¥ã«ã¯ããããããããªã¨ãã¾ã§ãã¦ããªã«ãããã¾ãã®ãã¨ãã£ã¦ãã ã³ã¤ããã¨æã£ãã§ããããã¨ãèããã¨ããã ãããã¹ãããã®ãè¸ããªããã§ãå°å¦çããã¨ãªããã¹ã©ã¤ãè¦ã¦çåã«æã£ããã¨å£ã«ãããï¼ãããããªãããªãã¨ãããã¨ã§ã²ã¼ã ãªãã§ãããã©ããããã¨ãªããããããããã¿ããªã²ã¼ã ã大好ãã ãã®ã
ã¦ã¤ã«ã¹ãé¡æã«ããã²ã¼ã ãå®ã¯çµæ§ããã¾ãããããã¬ãã²ã¼ã ã ã¨ãã¤ãªãã¶ã¼ãã«å§ã¾ããã¡ã¤ã³ã§ã¦ã¤ã«ã¹ãåºã¦ãããã®ããããã§ãªããã®ã¾ã§ããã¼ãã²ã¼ã ãããã¾ãã
ããã¯ç§ãé¢ç±³ããã¨ãã«ãåç£ã§è³¼å ¥ãããã®ã§ããããªããªãè¯ãã§ãã¦ã¦é¢ç½ãã§ããé£ç¹ã¯ã«ã¼ã«ãè¤éããã¦ã説æããã®ã大å¤ãªãã¨ãããã¢åãã¨è¨ãã°ããã¢åãã§ããã
iOSåãã²ã¼ã ã§ãããªã®ãããã¾ããããããè¯ãã§ãã¦ã¦ããããããããã¾ãããä¸çãçã£èµ¤ã«æãä¸ããå¿«æã
ãã¦ãã¦ãããã§ç´¹ä»ãããã®ã¯ããã¾ã§ã²ã¼ã ãªã®ã§ãã¡ãã£ã¨æè²ã®å ´ã§ã¯ä½¿ãã«ããããããã®ã¯ãªããã¨èª¿ã¹ã¾ããããªããªãåºã¦ããªãããããä½ã£ã¦ãã¾ããã¨èãã¦ããã£ã¨ãã¯ãã§ä½ã£ãã®ããã¡ãã®ã²ã¼ã ã«ãªãã¾ãã
ã¦ã¤ã«ã¹ããããã«ã¼ã
ãããããã¼ã
éã³æ¹ã¯ç°¡åã§ãã¦ã¤ã«ã¹ããããã«ã¼ãã§èªåã®ã¦ã¤ã«ã¹ããã¶ã¤ã³ãã¦ããããããã¼ãã®çªå·é ã«ãµã¤ã³ããæ¯ã£ãããè½åå¤ã§å ´ååããã¦ããã¤ã³ããã²ãããã¦ããã30ãã¤ã³ã以ä¸ã§äººãç æ°ã«ãããã¨ãã§ããã¨ãããã®ã§ããæ¡å¤30ãã¤ã³ãè¶ ããªãããã«ä½ã£ã¦ãã£ã¦ãã¦ã¤ã«ã¹ãè¦å´ãã¦ãã ãªãã¨æã£ã¦ããããã°ããããªã¨ãå®éã«å°å¦çã«ãã£ã¦ããã£ããã©ããªããªã好è©ã§ããããã»ã£ã¨ãã¾ããããããµã¤ã³ãã¯ã¢ããã¦ã¤ã«ã¹ã®ã«ãã·ãã¨åãå½¢ã®æ£äºåé¢ä½ãµã¤ã³ãã ãããªï¼ç´æã ãï¼
ããã¼åç´åãã¦éã«ä½ã£ãã®ã§ããã³ãã©ããã¯æºè¼ã ãã©ãå¿ç¨ãããããå¹ãããã«ãä½ãã¾ãããããããæ©ä¼ããããã³ã«å°ããã¤ã¢ãããã¼ããã¦ãããããªã¨æãã¤ã¤ã誰ãããã±ã¼ã¸åãã¦ãããªãããªãã¨ããããã使ã£ã¦ã¿ããæ¹ã¯ã¤ãã£ãã§ãç´æ¥ã§ããã¬ãã·ã¼ã§ããªãã§ãããã®ã§ãé£çµ¡ãã
ã¨ãã©ã¦ã¤ã«ã¹ç ï¼ã¨ãã©åºè¡ç±ï¼ãæ£ããæããããã«ï¼ï¼ï¼ââçºçãã¦ãªã人ããã¯ææããªãã£ã¦æ¬å½ï¼
ã¤ãã«æ¥æ¬ã§ãçãä¾ãã¨ããBSL4æ½è¨ç¨¼åããããã¨ãã対岸ã®ç«äºãã©ãã©ãè¿ã¥ãã¦ããããã«æãããã¾ãããå½ããã°ã¯ããããã¦ã¤ã«ã¹çè«æç´¹ä»ããã°*1ã§ã¯ããã¾ãããããããæã«æ å ±çºä¿¡ãã¦ããã ãã¼ï¼ã¨ãããã¨ã§ãä»åãå¼ãç¶ãã¨ãã©ã£ã¦ã¿ã¾ãããã
ä»åã¯ãã¨ãã©ã®åºç¤ç¥èã¨ãã¦è¯ãè¨ãããï¼ããã¦ãä¸å®ã«ãªã£ã¦ãã人ãå¤ãã ããã¨æãããï¼ãæ½ä¼æéã¯ã¦ã¤ã«ã¹ãæåºããªããã¨ããè¨èª¬ã«ã¤ãã¦ãè«æãç´¹ä»ãã¦ã¿ããã¨æãã¾ãã
ãã®åã«ä¸ã¤ã ããã¨ãã©ã®åºè¡ã¯ä»ã®åºè¡ç±ã¦ã¤ã«ã¹ã«æ¯ã¹ã¦ããå®ã¯ãããªã«æ¿ããããã¾ãããç²èããã®åºè¡ãç®ä¸åºè¡ãã»ã¨ãã©ã§ããããªãé¼»è¡ã©ã°ã¼ã£ï¼åè¡ãã¼ã¼ã£ï¼ã¨ããç®ããè¡æ¶ã ãã¼ã£ï¼ã¿ãããªãã¨ã¯èµ·ãã¾ããã®ã§ãããããã®ã¯ãã£ã¯ã·ã§ã³ã®ä¸ã§ã楽ãã¿ãã ããã
ã¾ãã¯こちらの論文ãçé èè
ã¯æ¥æ¬äººã
Host response dynamics following lethal infection of rhesus macaque... - PubMed - NCBI
ãµã«ã«ã¨ãã©ãå®é¨ææããã¦ãããã¼ããªãã©ã¡ã¼ã¿ã¼ãããã§ããã£ã¦å ·åã«è§£æããè«æã§ãããµã«ã§ã®ã¨ãã©ç±çç¶ã¯ãçºç±ã¨ç²èããã®åºè¡ãç®ä¸åºè¡ã§ãããããå§ã¾ãã®ãææ2-3æ¥å¾ãã¦ã¤ã«ã¹ãè¡ä¸ã«æ¤åºã§ããã®ãã»ã¼åãã¿ã¤ãã³ã°ã§ããããã ã確èªããã人ã¯Fig. 1Aã¨1Eï¼Viremiaï¼ã ãè¦ããããããããªãã§ããããããµã¤ãã«ã¤ã³ãååºå åãªã©ã®ç¥èããã人ã¯ä»ã®å³ãè¦ãã¨é¢ç½ãã¨æãã¾ããã¦ã¤ã«ã¹ãå¢æ®ããã¿ã¤ãã³ã°ã§ä¸ãã£ããä¸ãã£ãããæ«æã«ã¯ãããããµã¤ãã«ã¤ã³ã¹ãã¼ã ãèµ·ãã¦ã¾ãã
次の論文はこちらãZMAbã§ãµã«ãæ²»çããè«æã§ãããä»åè¦ãã®ã¯æ²»çã«å¤±æãã2é ï¼B2ã¨B3ï¼ã¨ã³ã³ããã¼ã«ã®1é ï¼C1ï¼ã®æ°åã§ãã
Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies
Table 1ãè¦ã¦ã¿ã¾ããããããã¯ãçµæçã«å£è ãé¼»è ãç´è ¸ããããã®ã¬ãã液ãRT-PCRã«ããã¦ã¦ã¤ã«ã¹æåºã®æç¡ãè¦ãå®é¨çµæã§ããNDã¯èª¿ã¹ã¦ãªãããã¼ãã¯æ¤åºéç以ä¸ãæ¤åºéçã¯1 PFU/mLãããã¯ããã¼ãã§ããã°ã¦ã¤ã«ã¹ã¯ããªãã¨è¨ã£ã¦ããããããã®æ°åã§ããFig. 2ã¨è¦æ¯ã¹ãªããèªãã¨ãã¨ãã©ç±ã®çç¶ãé²è¡ãå®æ¥½æ®ºããããå¾ãªãã£ãB2ãB3ãC1ã®3é ã¨ããå®æ¥½æ®ºç´åï¼ï¼å¤è¦ãããã¦èª¿åããããæªãããªç¶æ ï¼ã«ãªããªãã¨ã¬ãã液ããã¦ã¤ã«ã¹ãæ¤åºã§ããªããã¨ãåããã¾ãã
ã¡ãªã¿ã«ãæ²»çã§ãããµã«ã®ã¬ãã液ããã¯ã¦ã¤ã«ã¹ãã¾ã£ããæ¤åºã§ãã¦ã¾ããããã¦ãã§ããã
最後の論文はこちらããã¾ãçã«å復æã®ã話ã
Assessment of the risk of Ebola virus transmission from bodily flui... - PubMed - NCBI
æ²»çããå¾ãã©ã®ä½æ¶²ã«ã©ããããã®æéã¦ã¤ã«ã¹ãæåºãããããã調ã¹ãè«æãæ¯ä¹³ã精液ã«ããé·æéæåºããããã¨ãã話ã¯ãã®è«æãåºå ¸ã§ãããããä½æ¶²ã®ç¨®é¡ã«ãä¾ãã¾ãããããã1é±éç¨åº¦ãé·ãã¦1ã¶æ以ä¸ã¦ã¤ã«ã¹ãæåºãããã¨ãããã¨ã§ãæ²»çããæ£è ã解æ¾ãããã¾ã§ã«ã¯ãããããã®æéãè¦ç©ãããªãã¨ãããªãã®ã§ãã
ã¾ã¨ããã¨ãæ®éã®äººã触ããå±éºã®ãããä½æ¶²ãã§ããã¨ããã®å¾æ¶²ãææ³ç©ããã¯ãçç¶ãåºãã¾ã§ã¦ã¤ã«ã¹ã¯æ¤åºã§ãã¾ãããçç¶ãåºå§ããã¨ãè¡ä¸ã«ã¯å¤§éã®ã¦ã¤ã«ã¹ãæ¾åºããã¦ããã®ã§ãè¡ãæ··ãã£ãä½æ¶²ã«ã¯ç¹ã«æ°ãã¤ãã¾ããããã¨ããã¨ããã§ãããããå復ããæ£è ããã¯ãã°ããã¦ã¤ã«ã¹è£½é æ©ã«ãªã£ã¡ããã®ã§ãç³ã訳ãªãã§ããããã£ããæ¤æ»ã§ç¢ºå®ããã¾ã§ã¯éé¢ã§ãã
ã ããå®å¿ã ãã¨ããã¤ããã¯æ¯é ããã¾ãããä¼ãããã®ã¯ããããã£ãå®é¨çãªç¥è¦ã«å ããéå»ã®ã¢ã¦ããã¬ã¤ã¯ç¾å ´ã§ã®çµé¨ã®èç©ããããæ½ä¼æã®æ£è ã¨ã®ï¼é常ã®ç¯å²ã§ã®ï¼æ¥è§¦ã¯åé¡ãªããã¨ãã話ã«ãªãããç¾å°ãã帰ã£ã¦ããå»çé¢ä¿è ã®éé¢ã¯ããã1æ¥2åã®æ¤æ¸©ã21æ¥ãã¨ãã話ã«ãç¹ãã£ã¦ãããã¨ãããã¨ã§ããæºå¡é»è»ã®è©±ã«ã¯ã¡ãã£ã¨é£å·æ°å³ãªãã§ããããã¨ãããããã ï¼
*1:ããã表ç¾ãæ°ã«å ¥ããªãã£ããããããâ
ã¨ãã©åºè¡ç±ï¼ã¨ãã©ã¦ã¤ã«ã¹ç ï¼ãæ£ããæããããã«ââï¼ï¼ï¼ææ°ã®è«æãç´¹ä»ããã
æ¬å½ã¯æ²»çè¬ç¹éã¨ãã¾ã¨ãã¨ããããã¨æã£ã¦ãèªåã®è«æ*1æ¸ãã¦ãåéã«ããããè«æèªãã§ããã§ããã©ããã¡ãã¡ã§ã¾ã¨ãã¨ã解説ã¨ããããã§ã©ã¼ããã£ããªã¼ããã®ããã£ããè¿«åã®ããè«æãåºãã®ã§ãã¡ããç´¹ä»ãããã¨ã«ãã¾ããScienceãããèè ã®ãã¡5人ãã¨ãã©ã§äº¡ããªã£ã¦ããã¨ãããã¨ã§追悼記事ãåºã¦ãã¾ãã
è«ææ¬ä½ã¯ãã¡ãã
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
ã¿ã¤ãã«ã翻訳ããã¨ããµã¼ãã¤ã©ã³ã¹ã«ãã£ã¦æããã«ãªã£ãã2014å¹´ã«ã¢ã¦ããã¬ã¤ã¯ãèµ·ãããã¨ãã©ã¦ã¤ã«ã¹ã®èµ·æºã¨ä¼æã
2014å¹´3æã«ã·ã¨ã©ã¬ãªãæ¿åºç é¢ããã¼ãã¼ã大å¦ãããã¼ãç 究æãã±ããã¨ããé½å¸ã§ç«ã¡ä¸ããã¨ãã©ã®ãµã¼ãã¤ã©ã³ã¹ãããããªã5æã«æ¬ç©ã®ã¨ãã©æ£è ãè¦ã¤ãã¦ãã¾ã£ãã¨ããããè«æã¯å§ã¾ãã¾ãããã®å¾ã®ã·ã¨ã©ã¬ãªãã®æ··ä¹±ã¯ãåç¥ã®éãã§ãããèè éã¯ã5人ã®ç ç²è ãåºããªãããåå°ã§ãµã³ãã«ï¼æ£è è¡æ¸ ï¼ãåéããã·ã¨ã©ã¬ãªãã®ã©ãã§RNAãæ½åºãã¢ã¡ãªã«ã«éã£ã¦è§£æãè¡ãã¾ãã
éãããµã³ãã«ã¯æ£è 78人ããå ¨é¨ã§99ãåãæ£è ããæ¡è¡ãããã®ãå«ã¿ã¾ãããããå ¨é¨ã·ã¼ã¯ã¨ã³ã¹ãã¦ãããããã®ãµã³ãã«ä¸ã«ããã¨ãã©ã¦ã¤ã«ã¹ã®ï¼ã»ã¼ï¼å ¨é·RNAé åã決å®ãã¾ãããã¨ãã©ã¦ã¤ã«ã¹ã¯ãã¤ãã¹éRNAãéºä¼åã«æã£ã¦ãã¦ãã ããã1ä¸9åå¡©åºãããã®é·ããªã®ã§ãææ°ã®ã·ã¼ã¯ã¨ã³ãµã¼ã«ãããã°ãè¶ã®åããããã§ããæåã®15ãµã³ãã«ã使ã£ã¦æ¡ä»¶ã決ãã¦ãæ®ãã®84ãµã³ãã«ã¯ä¸æ°ã«è§£æãã¾ããã使ã£ãã®ã¯Illumina社ã®HiSeq2500ã1åå以ä¸ããææ°ãã·ã³ã§ãã
é å解æå¾ã®éºä¼å系統解æãã¹ãã¼ãã§ãå°ãåã®è«æã§ãããããã¦ããä¸å¤®ã¢ããªã«ã®ã¨ãã©ã¦ã¤ã«ã¹ã¨ã®é¢ä¿ããã£ãã解決ãä»ååºç¾ããã¦ã¤ã«ã¹ã¯ä¸å¤®ã¢ããªã«ããæ¥ããã®ããã®ãã¢ãéãã¦ã·ã¨ã©ã¬ãªãã«ãã£ã¦ããä¸é£ã®ãã®ã§ããã¨ãããã¨ãåããã¾ãããFig 2ã¨3ã®ç³»çµ±æ¨¹ãè¦ãã¨ãã®ãã¢ã§æ¡ããã¦ã¤ã«ã¹ããã·ã¨ã©ã¬ãªãã®ã¦ã¤ã«ã¹ãåããã¦ãã£ã¦ããã®ãè¯ãåããã¾ããã
ããã«ç´°ããè¦ã¦ã¿ãã¨ãã·ã¨ã©ã¬ãªãã®ã¦ã¤ã«ã¹ã«ã¯åæã®æ®µéãã2種é¡ã®ã¦ã¤ã«ã¹ãåå¨ãã¦ãããã¨ãåããã¾ããããã¯2種é¡ã®ã¦ã¤ã«ã¹ããåæã«ã®ãã¢ããï¼æææ¡å¤§ã®ãã£ããã¨ãªã£ãã¨è¨ããã¦ããã¨ãã©æ£è ã®è¬å¼ãä»ãã¦ï¼ã·ã¨ã©ã¬ãªãã«ä¾µå ¥ãã¦ãã¦ã人ã ã®éã§åºãã£ãã¨èããã¨è¾»è¤ãåãã¾ããã¾ããã·ã¨ã©ã¬ãªãå ã§ã®ä¼æãä¸æ§ã«æ±ãã西ã¸ã¨èµ·ãã¦ãããã¨ãåããã¾ããã10218çªç®ã®éºä¼åå¤ç°ãæã¤ã¦ã¤ã«ã¹ã¯ã·ã¨ã©ã¬ãªãå ã§åºç¾ããå¤ç°ã¯æéãçµã¦ã西ã¸ç§»åããã«å¾ã£ã¦å®å®ãã¦ãããã¨ãããã¦ã¤ã«ã¹ã®ä¼æã示ãæé©ãªææ¨ã¨ãªã£ã¦ãã¾ãã
ã¦ã¤ã«ã¹ã®å¤ç°ã¹ãã¼ããè¦ã¦ã¿ãã¨ãä»åã®ã¨ãã©ã¦ã¤ã«ã¹ã¯ã¨ã¦ãéãéºä¼åå¤ç°ãèµ·ããã¦ãã¾ãããã®äºå®ããä½ãçµè«ãå°ãããã«ã¯ãããªãå®é¨ãå¿ è¦ã§ãããã¢ã¦ããã¬ã¤ã¯ãåæããªããã°ãï¼çµæã¨ãã¦ä½ãèµ·ãããã¯åãããªããã®ã®ï¼ãã人éã«é©å¿ããã¨ãã©ã¦ã¤ã«ã¹ãåºç¾ããå¯è½æ§ãããã¨ãçè éã¯è¿°ã¹ã¦ãã¾ãã
ãã¦ãã¾ãæ°ã«ãªãã®ã¯ä»åè¦ã¤ãã£ãéºä¼åå¤ç°ã«ãã£ã¦ãå®æ¦æå ¥ããã¦ããZMappã®å¹ãã«å¤åãããã®ããªãã®ããã¨ãããã¨ã§ãããï¼ã§ã¯æ¬¡ã®Natureããåºãã°ããã®è«æãã©ããã
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
ã¿ã¤ãã«ã¯ãZMappã«ãããã¨ãã©ã¦ã¤ã«ã¹ç
ãé²è¡ããéé·é¡ã®å復ã
Figure 3ã«ä»ã¾ã§ãµã«ã¢ãã«ã§ä½¿ããã¦ããã¨ãã©ã¦ã¤ã«ã¹Kikwitæ ªã¨ä»åã®ã¢ã¦ããã¬ã¤ã¯ã§æ¡ããGuineaæ ªã®æ¯è¼ãããã¾ãã赤ç¢å°ã§ç¤ºããã¦ããZMappã®ã¨ããã¼ãã¯Guineaæ ªã§ãå¤ç°ãã¦ããªãã§ãããè¿åã«2ã¤ã¢ããé ¸å¤ç°ãããã¾ãããZMappã®çµåãä¸åæ´»æ§ã«ã¯å½±é¿ãã¦ããªããã¨ã
ããã§ã¯å ã»ã©ã®Scienceè«æã«æ»ããã·ã¨ã©ã¬ãªãã®æ ªãè¦ã¦ã¿ã¾ããããããµããªã®Table S4ã§ããZMappã¨ããã¼ãè¿åã«ã¯ãGuineaæ ªã§ãè¦ããã503çªç®ã®ã¢ã©ãã³ããããªã³ã¸ã®ç½®æ以å¤ã«ã¯ã¢ããé ¸å¤ç°ã¯è¦ããã¾ãããã¦ãã¨ã¯ãZMappã®å¹ãç®ãæãªããããªå¤ç°ã¯ä»ã®ã¨ããè¦ã¤ãã£ã¦ããªããä¸å®å¿ã§ããã
åãæ¥ãã1æéãããã§è«æèªãã§ã1æéãããã§æ¸ãã¦ã¿ã¾ãããæ·±ã話ã¯ã¾ãã®æ©ä¼ãããã°ã£ã¦ãã¨ã§ã
*1:ã¨ãã©ãããªãã§ãã¼
ã¨ãã©åºè¡ç±ãæ£ããæããããã«ââï¼ï¼ï¼ã¸ã®ã³ã¡ã³ãã«ãè¿äºãããªã©
photo by EU Humanitarian Aid and Civil Protection
ååã®ã¨ãã©ã®è¨äºã§ã¯ãå ´æ«ã®è«æç´¹ä»ï¼ããããã¦ã¤ã«ã¹éå®ã¨ããããã¢ãã¯æå端ãªãï¼ããã°ã«ããããã®åé¿ãé ããåæºãé ããããªãã¨ãããèã«éåæãè¦ãã¦éæ¿ããããªå¢ãã§ããã§ããæ¸ããããã¨ããã£ã¦ãèªãã§ããã人ãããã®ã¯å¹¸ããªãã¨ã§ããã
åé¿ã大ããã£ãåã大äºãªãã¤ã³ããææãããæ¹ããããããã¾ãããidã³ã¼ã«ãªã©ã¯ãã¾ãããããã¯ãã³ã¡ã³ããTwitterã§ã®ã³ã¡ã³ããªã©ã¸ã®ãè¿äºã§ããè«æç´¹ä»ã¯ãä¼ã¿ãã¤ã©ã¹ãããä¼ã¿ã
ãªãå»çå¾äºè ãææããã®ãï¼å®ã¯ç©ºæ°ææãã¦ãã®ã§ã¯ï¼
ããã¯ã¨ã¦ã大äºãªãã¤ã³ãã§ãããçµè«ããè¨ãã¨ãç¾å°ã§ã¯ã¨ãã©ã¦ã¤ã«ã¹ã®ææãé²ãã®ã«é©åãªæ°´æºãä¿ã¤ã®ãã¨ã¦ãé£ãããããã¨ããã®ãæ大ã®çç±ã§ã空æ°ææã¯ä»ã®ã¨ããåé¡ã«ãªã£ã¦ããªãã§ããNPRã§åããã¼ããåãä¸ãããã¦ãã¾ããã®ã§åèã¾ã§ã«ã
This Suit Keeps Ebola Out — So How Can A Health Worker Catch It? : Goats and Soda : NPR
ã¨ãã©ã¦ã¤ã«ã¹ã®ç 究ãè¡ãBSL4æ½è¨ã§ã¯ãç åä½ãæã¡åºããªãããç 究è ã®å½ãå®ããããã«ãä¸å ¨ã®ä½å¶ã§ã¨ãã¨ãã¾ã§æ¶æ¯ãè¡ãã¾ã*1ããã®ãéå°ã«æ¶æ¯ãã¦ãªã¹ã¯ãæ¸ãããã¨ãããªã¼ãã¼ãã«ãã¨ãå¼ã³ã¾ããã¾ãããã¥ã¼ãã³ã¨ã©ã¼ã«ããä¸ãä¸ãé²ãããã«ãããããä½æ¥ã¯æ¨æºåãããå ¨å¡ããã¬ã¼ãã³ã°åãã¦éµå®ãããã¨ãæ±ãããã¾ããæ¨æºåããã¦ãããããä½èª¿ãç²¾ç¥ç¶æ ã«ãã£ã¦ã¯äº¤ä»£ãã¦ããããã¨ãå¯è½ã§ããäºæ ãé²ãããã«é«é¡ãªæ©å¨ãæ¶èåã使ããã¨ã許ããã¾ããã´ã æè¢ãç ´ãã¦ããå å§ã¹ã¼ããã¦ã¤ã«ã¹ã®ä¾µå ¥ãé²ãã§ããã¾ãã
ä¸æ¹ã§ã¢ã¦ããã¬ã¤ã¯ã®è¨åºç¾å ´ã§ã¯ã©ãã§ããããï¼ç©è³ãè¨åãéããã¦ãããããã¾ã人éãç¸æã®ãããããªã¼ãã¼ãã«ãã¨ã¯ã¨ã¦ãè¨ããªãç¶æ³ã§ããä½æ¥ã¯ããç¨åº¦æ¨æºåã§ãã¾ãããæé ã®è¦ç´ãããã¬ã¼ãã³ã°ã«ååæéãããããã¨ã¯ã§ãã¾ãã*2ãä½èª¿ãæªããªã£ã¦ãã¾ã£ãããèªåãã¨ãã©ã«ææãããã¨çããªãã¦ã¯ãããªãç¶æ³ã§ããç¹ã«ãã¨ãã©åºè¡ç±ã§è¡ç®¡ãã¼ãã¼ãã«ãªã£ã¦ãã¾ã£ãæ£è ããæ¡è¡ããããç¹æ»´ã®ã«ã¼ã確ä¿ããããããã®ã¯é£ããã§ãããæèãããããã¨ãã¦æ´ãã人ããã¾ããããããé²è·è¡£ãçã¦ãã´ã¼ã°ã«è¶ãã«è¦ãªããã2é3éã®ã´ã æè¢ãã¯ãã¦è¡ããªãã¦ã¯ãªãã¾ãããã´ã æè¢ãç ´ãããã身ãå®ã£ã¦ããããã®ã¯ããã¾ããã
確ãã«ãææçã«ç²¾éããå»å¸«ãçè·å¸«ãææãã¦ãã¾ãã¨ããã®ã¯ãã«ããã«ä¿¡ãããã¾ãããããããã¦æ¯è¼ãã¦ã¿ãã¨ãããã«ç¾å ´ãå±éºã§ãããåããã¨æãã¾ããæåç·ã§æ¦ãå»çå¾äºè ã«ææè ãåºã¦ããã®ã¯ãããã ãæ£è ã¨ç´æ¥æ¥è§¦ããã¦ã¤ã«ã¹ã«æ´é²ãããæ©ä¼ãå¤ãããã¨ãããã¨ãªã®ã§ããããã空æ°ææã§æ¡ãã£ã¦ããã¨ããã°ãå»çå¾äºè 以å¤ã®ãµãã¼ãã¹ã¿ããã«ãææãæ¡ãã£ã¦ãã¦ããããããªãã§ãããããã£ã¨ã²ã©ãç¶æ³ã«ãªã£ã¦ããã®ã§ã¯ãªãã§ããããã
ããããããã§ãããããããå¯ä»ãã¾ããããMSFæ¥æ¬ã¸ã®å¯ä»ã¯ãã¡ãããï¼
今回の寄付受付入力画面 | 国境なき医師団日本
空æ°ææã¨é£æ²«ææ
ããããã¡ãã£ãæãããµãã¦ã¾ããã©ãååã®è¨äºã§ã¯ãã®2ã¤ããã¾ãåºå¥ãã¦ãã¾ãã*3ãå®é¨çã«ç©ºæ°ææï¼ï¼é£æ²«æ ¸ææï¼ãªã®ãé£æ²«ææãªã®ããåºå¥ããã®ã¯çµæ§å¤§å¤ãªãã§ãããã人工çã«ä½ã£ãé£æ²«æ ¸ã¯ããã¾ã§ãã¢ãã«ã§ãããé£æ²«ææãæç«ããç¶æ³ã§ã¯é£æ²«æ ¸ææãæç«ããããã§ããããã«ããã空æ°ä¸ãæ¼ã£ããé£ãã ããã¦ããã¨ãã©ã¦ã¤ã«ã¹ãå¸ãè¾¼ãã§ææã¨ããçµè·¯ã¯ãã¨ãã©ã®æ¡æ£ã«ãã¾ãå¯ä¸ãã¦ããªããã£ã¦ãã¨ãä¼ããã°ããããªã£ã¨ï¼ãã¾ãããï¼ï¼ãè¶ãæ¿ããï¼ï¼è¡éº»èåããããããï¼ã
æºå¡é»è»åé¡
ããã®ç¤¾çãï¼ãã¨ç½µãããã®ã¯ãã¾ãã¾ã§ãããã¡ãã£ã¨ã ãã¾ããã«èãã¦ã¿ã¾ãããããã·ã¨ã©ã¬ãªããã®ãã¢ããªããªã¢ã®3ã«å½ãã¢ã¦ããã¬ã¤ã¯ã®ä¸å¿ã§ãããããå½é空港ãããã¾ããããããæç°ãé¢ç©ºã¯ãã¡ãããé¦æ¸¯ãä»å·ãã·ã³ã¬ãã¼ã«ãããã¤ã¨ãã£ãããªãã¿ã®ãã空港ã«ã¯ç´è¡ä¾¿ããªãããã§ããããã³ãã³ãããªãã¢ã ã¹ãã«ãã ãããªã¥ãã»ã«ããããæ°ã«ãªãã¨ããã§ãããããä¾ãã°ã·ã¨ã©ã¬ãªãå½å ã®ç§»åã§1-2æ¥ããã³ãã³ã«çãã¾ã§ããã«åæ¥ãæç°ã¾ã§ç´è¡ä¾¿ã§åæ¥ã¡ãããçµç±ä¾¿ã§1æ¥ããæçã«ã¼ãããªã丸2-5æ¥ããããããããã§ãããã¨ãã©ã®æ½ä¼æéã¯2æ¥ãã3é±éç¨åº¦ã®ãããã©ããã§ææãã人ãæ°ã¥ããã«æ¥æ¬ã¾ã§æ¥ã¦ãã¾ãå¯è½æ§ã¯ãªãã«ããããããå°çããé ã«ã¯é¢¨éªæ§ã®è»½ãçç¶ãåºå§ãã¦ããã§ããããããæ¤ç«ã§ç³åããããææçå¤æ¥ãå診ãã¾ãããã
ãµã¦ã¸ã¢ã©ãã¢ã®æ»äº¡è ã¯ã·ã¨ã©ã¬ãªãããã®è¼¸å ¥ä¾ï¼ã¾ã 確å®ãã¦ããªãï¼ã ã¨ããã¨ãåæ§ã®ã±ã¼ã¹ã¯ã©ãã§èµ·ãã¦ããããããªããã¨ãããã¨ã«ãªãã¾ããæ¥æ¬ã¨ä¸ã«ããã3ã«å½ã®ãã¸ãã¹ã£ã¦ã©ããªæããç¥ãã¾ããããç´æ¥å ¥ã£ã¦ããã±ã¼ã¹ã¯ããªãéå®ããã¾ãããæ¤ç«ã§ãææ¡ï¼è¿½è·¡ããããã®ã§ããã¯æ¥½è¦³è¦ãã¦ãããããããããããã¨ã¼ãããã®ãã空港ãçµç±ãã¦æ¡ãã£ã¦ãã¾ã£ãå ´åãè¦æ³¨æã§ãããã
ããã ã注ç®ãéã¾ããä¸å®ãé«ã¾ã£ã¦ããã®ã§ãæ¥æ¬ã«ææè ãå ¥ã£ã¦ãããã¨ã¯ãã¶ããªãã§ããããããå ¥ã£ã¦ãããï¼ææè ãæºå¡é»è»ã«ä¹ã£ã¦ãããï¼æåã®ã±ã¼ã¹ã«å·»ãè¾¼ã¾ããªããã¨ãç¥ãä»ããã¾ãããæåã®ã±ã¼ã¹ããã¥ã¼ã¹ã«ãªã£ããæºå¡é»è»ã¯æ¥æ¬ããæ¶ããã§ãããããããã®æã¯ä¿å¥æãªã©ã®æ示ã«å¾ãã¾ããããã
*1:å»æ£ç©ãææ°´ã¯å ¨é¨ãªã¼ãã¯ã¬ã¼ãã§æ» èãã¾ããã人éã¯æ» èããã¨æ»ããããã®ã§ãæ¶æ¯ã§ãã
*2:ãããã§ããã®ã¯ä½åã®ããä¸é¨ã®NGOï¼ï¼MSFï¼ã¨å ¬çæ©é¢ããæ´¾é£ããã¦ããã°ã«ã¼ãããã
*3:ã¤ã³ãã«ã空æ°ææã¨ãæ¸ãã¡ãã£ã¦ããã»ã»ã»ä¿®æ£ãã¾ãã
ã¨ãã©åºè¡ç±ãæ£ããæããããã«ââï¼ï¼ï¼ç©ºæ°ææããã®ãããªãã®ãï¼
西ã¢ããªã«ãç¹ã«ã·ã¨ã©ã¬ãªãã§èµ·ãã¦ããã¨ãã©åºè¡ç±ã®ã¢ã¦ããã¬ã¤ã¯ããªããªãçµæ¯ãããä¸ã®ä¸ããããããã¦ãã¾ãããææãæ¡å¤§ãã¦ãã¾ã£ã大ããªè¦å ã¨ãã¦ãé½å¸ã§ã®çºçã¨è¨ãå°ççè¦å ã®ä»ãç¾å°ã®äººãã¡ã®æè²æ°´æºãæåçèæ¯ãããã¦æ¿æ²»ä½å¶ã®åé¡ãããã®ã¯çãããããªããã¢ã¦ããã¬ã¤ã¯ã®çµæ¯ã«ã¯ã¾ã ã¾ã æéããããããã§ãã
å½éçãªæ³¨ç®ãéããã£ããã¨ãªã£ãä¸ã¤ã®åºæ¥äºã«ãã¢ã¡ãªã«äººã®ææè ãæ¬å½ã«ãã£ã¼ã¿ã¼æ©ã§è¼¸éãããç é¢ã«å容ãããã¨ãããã®ãããã¾ãããæ²»çã«ä½¿ããã¦ããã¨ããæªæ¿èªè¬ãå«ããä¸é£ã®ã¢ã¡ãªã«ã®åãã¯æ¿æ²»åå¦ã®çºé²ã§ãããã¨ã¯å¦ããã諸æãæãã¦ãã¢ã¡ãªã«ããããã¨ã¯è¨ããªãç¶æ³ã§ãããã©ãããç´ãã®ããæ¼ãã§ç 究éçºãé²ãã®ãäºå®ã§ããã¾ããæ¸ æ¿ä½µåãã¦çªãé²ãã¢ã¡ãªã«ã®ãã¯ã¼ãæãç¥ãããã¾ãã
ãã¦ãå½ããã°ã¯è«æç´¹ä»ããã°ã§ãã®ã§ãã¢ã¦ããã¬ã¤ã¯ã®ãã¥ã¼ã¹ã追ããããã®ã¯ä»ã®äººã«ä»»ããã¨ãã¦ãè«æãç´¹ä»ããªããã¨ãã©ã«ã¾ã¤ããçåãå°ãã§ã解æ¶ã§ãããããæ¸ãé£ãã¦ã¿ããã¨æãã¾ããé·ããªããããªã®ã§å ã«çµè«ã ãç½®ãã¦ããã¾ããã
- ã¨ãã©ã¦ã¤ã«ã¹ã ã£ã¦ã¦ã¤ã«ã¹ã ãã¦ã¤ã«ã¹ã®éçã¯è¶ ããããªãã
- ããªãã«ä»ã§ãããã¨ãåå¼·ãå¯ä»ãã¤ãã§ã«ä»ã®ææçãç解ãããã
å½¼ãç¥ãå·±ãç¥ãã°ç¾æ¦æ®ããããå½¼ãç¥ãããã¦å·±ãç¥ãã°ãä¸åä¸è² ããå½¼ãç¥ããå·±ãç¥ãããã°ãæ¦ãæ¯ã«å¿ ãæ®ããï¼å«åï¼
ã¦ã¤ã«ã¹ã®ãã¨ã ããããªãã人éã®ãã¨ãç¥ã£ã¦ãæ£ããæããã¾ãããã
ã¨ãã©ã空æ°ææããã£ã¦æ¬å½ï¼
ãã¨ãã©ã¯ç©ºæ°ææããã¼ããããããããããããããçªç¶å¤ç°ã¨ãããããããªãã®ï¼ããªã©ã¨ãããã£ã¨ãªããã®å¤§ããªçåã§ãããçãã¯ããã¶ãããããã§ã大ãããã¨ãªããã§ãã
ã¾ããå°ãåã«è©±é¡ã«ãªã£ãè±ããç¿ã¸ã®ç©ºæ°ææã®è«æãè¦ã¦ã¿ã¾ããããããããã®Scientific Reportsããã
è±*1ãã¨ãã©ã¦ã¤ã«ã¹ã«ææããã¾ãããåãé¨å±ã«ç¿ã4é 飼ã£ã¦ããã¨ãã¤ã®éã«ãå
¨é ææãã¡ããã¾ãããå ´æã¯é¢ãã¦ãããæ°ãã¤ãã¦æé¤ããã®ã§ãè±ããç¿ã¸ã¯ç©ºæ°ææã§ããããã¨ããè«æã§ããä½ã§ãã®è«æé¸ãã ãã£ã¦è¨ãã¨ãサプリのFig 1(リンク先PDF注意)ã«å®é¨å®¤ã®åçããããããªãã§ãããããããã®è·é¢ãªãã24æéåãé¨å±ã«ãããææãã¡ãããã¨ããã¾ããã£ã¦ãã¨ãè¨ãããã®ã§ãæ¯éè¦ã¦ä¸ããã
ãããç¿ããç¿ã¸ã¯ã©ã¼ãªã®ï¼ã¨ããçåã§ããããã¡ããè«æãåºã¦ã¾ãã¦ãたとえばこれã¯ãã³ã³ããã¼ã«ã®ç¿ã«é£ã³ç«ãã¡ãã£ãããããâã¨ããè«æã§ããã¡ãªã¿ã«è±âç¿å®é¨ã®ç 究æã§ã¯ãéå»ã«åãã±ã¼ã¸ã使ã£ã¦å®é¨ãã¦ããã©ç¿ããç¿ã¸é£ã³ç«ãããã¨ã¯ãªããªãã¨ã®ãã¨ã§ãããä»ã«ã¯ãã¨ãã©ã¦ã¤ã«ã¹ãç¡çããã¨ã¢ãã¾ã«ã«ãã¦å¸å¼ããã¦ããè«æãããã¤ãåºã¦ãã¾ããこれã¨ãこれã¨ããè³é¼»ç§ã§ããªãã¿ã®ããã©ã¤ã¶ã¼ã使ã£ã¦ãã¨ãã©ã¦ã¤ã«ã¹ãç¿ã«å¸ãããã¨ææãã¦ã¨ãã©åºè¡ç±ã§æ»ã«ã¾ãã
ç«å¦çã«ã¯ã©ããªãã§ãããï¼ãããªè«æãåºã¦ãã¾ãã1995å¹´ã®ã¢ã¦ããã¬ã¤ã¯ã®èª¿æ»ã
Ebola hemorrhagic fever, Kikwit, Democratic Rep... [J Infect Dis. 1999] - PubMed - NCBI
è«æä¸ã§ã¯5人ã®æ£è ã«ã¤ãã¦ãã¨ãã©æ£è ãè¦èãã«ç é¢ã«ã¯è¡ã£ããã®ã®ãæ£è ã«ç´æ¥è§¦ããªãã£ãï¼ç©ºæ°ææã®çãããããã¨ãã¦ãã¾ãããããããã以éã«åºã¦ããã©ã®è«æã§ãã空æ°ææã®çãä¾ã¯å ±åããã¦ãã¾ããããæ£è ãæ£è ã®ä½æ¶²ã¨ã®æ¥è§¦ãæãæåãªæææºã§ããã¨ã®çµæãåºã¦ãã¾ãã
ç¹ã«ã2000-2001å¹´ã®ã¦ã¬ã³ãã§ã®ã¢ã¦ããã¬ã¤ã¯ãæ±ã£ãこの論文ã§ã¯ãæ£è ã¨åãç°¡æç æ£ï¼é ä¸ãªãã³ãã¿ãããªãã®ï¼ã§ä¸æ©ãæããããã¨ã¨ã2次ææãããã¨ã®éã«ã¯å¼±ãç¸é¢ãããªããã¨ããçµæãåºã¦ããã空æ°ææã¯ã¨ãã©ã®ææã«ã»ã¨ãã©å¯ä¸ãã¦ããªãã ããã¨çµè«ãã¦ãã¾ãã
ã¨ãã©ã¦ã¤ã«ã¹ã¯ç°å¢ä¸ã§èå¼±ã§ãç³ãããã¢ã«ã³ã¼ã«ã§ãæ¥éã«æ» èãããã¨è¨ããã¦ãã¾ããä¸æ¹ã§ãéçæ£è ã®è¡æ¶²1mlããã10ã®6ä¹åã»ã©ã®ç²å*2ãããããããæ°ç¾ç¨åº¦ä½å ã«å ¥ãã¨ï¼ã¨ã¢ãã¾ã«ææã§ãï¼ææãæç«ãããã¨ãåãã£ã¦ãã¾ãã
ãããã£ãå®é¨çãç«å¦çãªç 究ã®ç©ã¿éãã®çµæãWHOãCDCã¯ç©ºæ°ææã®ãªã¹ã¯ã¯æ¥µãã¦ä½ãã¨è¦ç©ãã£ã¦ãããæ£è ãæ£è ã®ä½æ¶²ã¨ã®æ¥è§¦ã«æ³¨æãæãããå§åãã¦ããã®ã§ãã
ã§ã¯ãçªç¶å¤ç°ãèµ·ãããã¨ãã©ã¦ã¤ã«ã¹ã人ãã人ã¸æ¿ãã空æ°ææããããã«ãªãå¯è½æ§ã¯ããã®ã§ããããï¼ãªããã¨ã¯è¨ããããªãã®ã¯ãã¡ããã§ããããã¶ãããªãã§ããããã«ãã¤ã³ãã«ã¨ã³ã¶ã¦ã¤ã«ã¹éº»ç¹ã¦ã¤ã«ã¹ãå£è¹ç«ã¦ã¤ã«ã¹ã®ããã«ç©ºæ°ææã§æ¡æ£ããããã«ã¯ãææè
ãåãåããã¨ã®ã§ããææï¼ï¼æ½ä¼æéãçç¶ãæ¿ãããªãåï¼ã«ã¨ã¢ãã¾ã«ã«ãªãããã鼻水ãå¾æ¶²ä¸ã«ã¦ã¤ã«ã¹ã大éã«æ¾åºããããã¨ããã¢ã§ããã¨ãã©ã¦ã¤ã«ã¹ã¯æ½ä¼æéä¸ã¯ã»ã¨ãã©ä½å¤ã«åºã¾ããããä¸åº¦çç¶ãå§ã¾ãã¨å³ããããã¿ã©ããã§ã¯ãªããªã£ã¦ãã¾ãã¾ãããã®ããã空æ°ææã§åºããã¨ãã©ã¦ã¤ã«ã¹ã¯ããã¶ãããããªã«æãããã¾ãããã¨ãã©ã¦ã¤ã«ã¹ã ã£ã¦ã¦ã¤ã«ã¹ã ãã¨ãããã¨ã§ãã
*1:ä½ã§è±ï¼ã¨ããã¨ã話ãé·ããªãã®ã§ç«¯æãã¾ãããã¬ã¹ãã³ã¦ã¤ã«ã¹ã¨ããã¨ãã©ã®å å¼ããã£ãªãã³è¾ºãã«ãã¾ãã¦ã人ã殺ãããã¨ã¯ãªããã§ããã©ãè±ãã人ã¸ææãããããã¨ããç«å¦èª¿æ»ã®çµæãããã®ã§ãããããã¨ãã©ã§ãå®é¨ãã¦ã¿ãããï¼ã¨ããè«æã§ããã
*2:ã¡ãã£ã¨èªå¼ã¯ããã¾ãããããã©ãã®ã§ãã®ã¾ã¾ã«ãã¦ããã¾ãã
ããåããºãã¯ãã³ã°åºè¡ç±ã®æªå¤¢ãè¦ããï¼
ï¼ãããã¶ãããã¦ããã¾ãï¼ï¼èã®é³´ããããªå£°ã§ï¼ï¼ãã³ã°ã ãã«ï¼
Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice.
J Virol. 2013 Nov;87(21):11648-58. doi: 10.1128/JVI.01156-13. Epub 2013 Aug 21.
ä¹
ãã¶ãã®æ´æ°ã¯å®å¿ã¨å®å®ã®J Virolããã
顧ã¿ãããªãç±å¸¯ç ï¼Neglected Tropical Diseaseï¼ã®4çªããã¿ã¼ãã¨ãã³ã°ç±ãä»åã®ä¸»å½¹ã§ããè´æ»çã¯1ï¼ ä»¥ä¸ã¨ããã®æã®ã¦ã¤ã«ã¹ææçã«ãã¦ã¯ä½ãã§ã¯ãããã®ã®ãèã®çæ ã®åä»ãã¨å°çè¦æ¨¡ã®åå¸ã§ãæ¯å¹´æ°åä¸äººåä½ã§æ£è ãéç£ããé·è·é¢æè ã§ããåå ã¨ãªãã®ã¯ãã©ãã¦ã¤ã«ã¹ç§ãã³ã°ã¦ã¤ã«ã¹ããã³ã°ã¦ã¤ã«ã¹ã«ææããã¨ãé«ç±ã¨ãé¢ç¯ã骨ã®çã¿ãä¸éæ§ã«èµ·ãã¾ããããããã³ã°ç±ã§ããããã¦ãã¯æ²»ãã¾ãã
æãã®ã¯ãçºç±ãåã¾ã£ã¦ããããªï¼ã¨ããé ã«åºè¡ç±ã«çºå±ãã¦ãã¾ããæ»ã«è³ãã±ã¼ã¹ã§ããããããã³ã°åºè¡ç±ã¨è¨ãã¾ãã
ãã¦ãã¦ãææçã®ç 究ã¨åã£ã¦ãåããªãã®ãå®é¨åç©ãç¨ããã¢ãã«ãªããã§ããããã³ã°åºè¡ç±ã®ã¢ãã«ä½ãã¯ãã¾ããã¾ãããã¾ããã§ããããã¦ã¹ã¯ãã¡ãããä»ã®åç©ããããã試ãã¦ã¿ã¾ãããã¢ãã«ã«ã¯ã»ã©é ãã¦ããµã«ã使ããããªããã§ãªãã®ï¼ã¨ããã¨ãã¾ã§ãã©ãçãã¦ãã¾ããã財å¸çã«ã¡ãã£ã¨è¦ããç¶æ³ã ã£ãã®ã§ããããã®ãµã³ãã«ã¯ãã®æã®ç±å¸¯ç ã®å¸¸ã§ãå»çä½å¶ãã¾ã¾ãªããªãå°åã§å ¥æããã®ã¯è³é£ã®æ¥ã§ãã
ããã§ç 究è ãã¡ãæãè³ã£ãã®ããé è¡ç³»ã®ç´°èãã¾ãã£ã¨ããã®ãã®ã«ç½®ãæããããåãã¦ã¹ã§ããã¦ã¤ã«ã¹æ§åºè¡ç±ã¯ãããããã£ãã°ããã«è¨ãã°ãã¦ã¤ã«ã¹ãæªããã¦è¡ãæ¢ã¾ããªããªãç æ°ã§ãããã¦ã¹ã§ãã³ã°åºè¡ç±ãèµ·ããªãã®ã¯ããºãããã ãããããï¼âæã£ãéãããåãã¦ã¹ã¯åºè¡ç±ã®ãããªçç¶ã示ããã®ã§ãããã¨ããã¨ããã¾ã§ãèæ¯ãããåãã¦ã¹ä½ãã¨ããµã«è²·ã£ã¦ãããã大å¤ãªããããã¼ã®ï¼ã¨ããéæ®ãªçªã£è¾¼ã¿ã¯ç¦æ¢ãªï¼*1
ã¨ããããã§ãããåãã¦ã¹ãä½ãã¾ãããã²ã¨å·¥å¤«ãã¦éª¨é«ã®é è¡ç³»ã ããããªããèèã®ç´°èãä¸é¨ããåãããã¦ã¹ãã§ãã¾ãããããã§ããã³ã°åºè¡ç±ã§ã©ããã¦è¡ãæ¢ã¾ããªããªãåºè¡ç±ã«ãªãã®ããããæ£ç¢ºã«èª¿ã¹ãäºãã§ãã¾ãããªããªããæ¢è¡ã®éã«æåç·ã§åºã¾ãå½¹ç®ãæ
ãè¡å°æ¿ã®ç£çã«ã¯ã骨é«ã«ããå·¨æ ¸çã¨ããç´°èã¨ãèèã§ä½ãããããã³ããã¨ãã³ã®ä¸¡æ¹ãå¿
é ã§ãã©ã¡ããæ¬ ãã¦ãããã®æ¢è¡æ©æ§ãåç¾ãããã¨ã¯ã§ããªãããã§ãã
ã¾ãããã³ã°åºè¡ç±ã«ãªã£ã¦ãã¾ã£ãæ£è
ã§ã¯è¡å°æ¿ãé¡èã«æ¸å°ãããã¨ãç¥ããã¦ãã¾ããè¡å°æ¿æ¸å°ã®è¬ã追ããã¨ã§ãåºè¡ç±ã«ãªãä»çµã¿ã解ãæãããã¨ãã試ã¿ã§ããã
ãã®ããåãã¦ã¹ã«ãã³ã°ç±ã¦ã¤ã«ã¹ãææãããã¨ãããã®è¡å°æ¿ã ãããããå°ãªããªãã¾ããå·¨æ ¸çãå°ãªããªããå·¨æ ¸çã«ãªãåã®ç´°èãã¡ãå°ãªããªãã¾ããããèèã®ããã³ããã¨ãã³ç£çã¯ãã¾ãå¤ããã¾ãããå·¨æ ¸çèªä½ã«ã¯ã©ãããã¦ã¤ã«ã¹ã¯ææãã¦ããªãããã§ã*2ãã骨é«ããã¦ã¤ã«ã¹ãè¦ã¤ããã¾ããã骨é«ä¸ã®ããç´°èã®å²åãã¡ããã¡ããã¨å¤ãã£ã¦ãã¾ãã
ãããã®çµæãããçè
ãã¡ã¯å·¨æ ¸çã¸ã®ååããµãã¼ããã骨é«ä¸ã®ç°å¢ãã¦ã¤ã«ã¹ææã§ãã¡ã¼ã¸ãåããçµæã¨ãã¦è¡å°æ¿ãæ¸å°ããã®ã§ã¯ãªããï¼ã¨ããæ¨æ¸¬ããã¦ãã¾ãã
ãã³ã°ã¦ã¤ã«ã¹ã«ããè¡å°æ¿æ¸å°ã®ã¡ã«ããºã ã¨ãã¦ã¯ãé·å¹´ãæä½ã«ãããã®ã§ã¯ãªããã¨èãããã¦ãã¾ããããå®é¨çã«ã確ããããã¦ãã¾ããä¸æ¹ã§ãä»åã®ããåãã¦ã¹ã¢ãã«ã§ã¯ãæä½ã®å¿çããªãã¦ãè¡å°æ¿æ¸å°ã骨é«ã¬ãã«ã§èµ·ãããã¨ãåããã¾ããããã¦ãã¦ãæ¬å½ã®ã¨ããã¯ã©ããªãã§ãããï¼ã©ã¡ãã®ã¡ã«ããºã ãããå¾ããã§ãããã²ãã£ã¨ããããåæ¹ã®å¾®å¦ãªãã©ã³ã¹ãæç«ããæã«ã ããã³ã°åºè¡ç±ãèµ·ããã®ããããã¾ãããã¾ã ã¾ã ãç 究ããªããã°ãããªããã¨ã¯ããããããããã§ããï¼ç 究費ãã£ã¨ã¡ããã ãï¼ã
*1:å®éã®ã¨ãããBSL3ã¨ã4ã®æ½è¨ã§ãµã«ãæ±ãã®ã¯æåãããµã«ç¨ã«ãã¶ã¤ã³ããã¦ãªãã¨è¾ãã®ã§ããã¦ã¹ã§ç 究ã§ããã«è¶ ãããã¨ã¯ãªãã®ã§ã
*2:ããã¯æç« ã§è§¦ãããã¦ãã ãã§çµæã示ããã¦ãªãã®ã§ãã¡ãã£ã¨çåãæ®ã
ã¦ã¤ã«ã¹å®¶ç´
ç¾ä»£å®¶ç´ã¨ããã話é¡ãããã§ããã
見たことあるあのマークを家紋に 「#現代家紋」 - Togetterまとめ
化学家紋 : 有機化学美術館・分館
æµãã«ä¹ã£ããã®ãã¢ã¬ã§ããã©ãåã ããã¦ã¤ã«ã¹ã家ç´ã¿ãããããé¢ç½ãããªã¼ï¼ã¨æã£ã¦ãã¦ãã¡ããã¡ããèãã¦ãã®ãç½®ãã¦ããã¾ããã
ãããããã¡ãã£ã¨çºå±ããã¦ãã¦ã¤ã«ã¹ã®æ§è³ªã¨ãè¦ããã®ã«ä½¿ããããããªã¼ãªãã¦ãDNAã¦ã¤ã«ã¹ãããªãã®ã¯ãæå¬ã
追è¨ï¼ãã¼ã«ãã«ã°ã¦ã¤ã«ã¹ã®èª¬æãåæ³èç½è³ªæã«ãªã£ã¦ããã®ã¯ç¡ãã®ééãã§ããã³ããã³ããã§ï¼